Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect an overall neutral to cautiously optimistic attitude, citing the microbiota changes and potential anti-inflammatory benefits demonstrated by the study. Words like 'stimulated growth' and 'evaluate' indicate interest and recognition of the study's importance, while mentions of needing further research suggest a measured perspective on its immediate clinical impact.
Most discussions acknowledge the positive effects of sodium butyrate on gut microbiota in IBD patients, showing a general consensus about its potential benefits.
The discussions display moderate curiosity, with some participants highlighting the study's findings, but without extensive exploration.
Participants show some depth by referencing specific details like microbiota modulation and clinical implications, but the overall engagement remains moderate.
The discussions hint at potential significance for treatment, yet recognize that further research is needed, indicating moderate perceived impact.
In a pilot double-blind placebo‐controlled study in 49 #IBD patients oral microencapsulated‐sodium‐butyrate for 2 months with conventional therapy stimulated growth of butyrogenic/SCFA producing bacteria, no effect on clinical activity https://t.co/PTOnGurQVF @ANMSociety @esnm_eu
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. https://t.co/co6HhJQJwY
RT @NGMJournal: In a pilot double-blind placebo‐controlled study in 49 #IBD patients oral microencapsulated‐sodium‐butyrate for 2 months wi…
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. https://t.co/p4CGE8nRga https://t.co/85WS3eYz69
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease https://t.co/wftUB21Q23
Congrats to the whole Team for this pilot study to evaluate the modulation of the #gut #microbial composition after #butyrate treatment in a group of #IBD patients. https://t.co/wqPMcFO2rD #microbiota
This video explores how microencapsulated sodium butyrate influences gut microbiota in inflammatory bowel disease patients, promoting beneficial bacteria and potentially reducing inflammation, with implications for…
This video examines common misconceptions about sodium bicarbonate in dairy and supplements, explaining that it does not have anti-inflammatory effects or health benefits as marketed. It discusses natural sources…
This study examined how microencapsulated sodium butyrate influences gut microbiota in patients with inflammatory bowel disease, including Crohn's and ulcerative colitis. Results showed increased beneficial bacteria…
This video discusses how microencapsulated sodium butyrate influences gut microbiota in inflammatory bowel disease patients, including Crohn's disease and ulcerative colitis, with potential anti-inflammatory benefits…
RT @NGMJournal: In a pilot double-blind placebo‐controlled study in 49 #IBD patients oral microencapsulated‐sodium‐butyrate for 2 months wi…
In a pilot double-blind placebo‐controlled study in 49 #IBD patients oral microencapsulated‐sodium‐butyrate for 2 months with conventional therapy stimulated growth of butyrogenic/SCFA producing bacteria, no effect on clinical activity https://t.co/PTOnGurQVF @ANMSociety @esnm_eu
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease https://t.co/wftUB21Q23
Congrats to the whole Team for this pilot study to evaluate the modulation of the #gut #microbial composition after #butyrate treatment in a group of #IBD patients. https://t.co/wqPMcFO2rD #microbiota
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. https://t.co/p4CGE8nRga https://t.co/85WS3eYz69
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. https://t.co/co6HhJQJwY
NM
SP
PA
M
JA
BS